News - Generics, USA

Filter

Current filters:

GenericsUSA

Popular Filters

1 to 25 of 84 results

Hospira’s Retacrit effective in chemotherapy-induced anemia

Hospira’s Retacrit effective in chemotherapy-induced anemia

24-07-2014

USA-based Hospira, a leading provider of generic injectable drugs and infusion technologies, announced…

BiosimilarsErythropoiesis-stimulating agentsGenericsHematologyHospiraInfusion technologiesResearchRetacritUSA

Hikma to take over Boehringer’s Ben Venue manufacturing site

24-07-2014

Jordan-based drugmaker Hikma Pharmaceuticals says it has agreed with Ben Venue Laboratories, part of…

Ben Venue LabsBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsProductionUSA

US court preliminary order to prevent Actavis launch of generic Gralise

US court preliminary order to prevent Actavis launch of generic Gralise

18-07-2014

Judge Joel Pisano of the US District Court for the District of New Jersey has entered an order preliminarily…

ActavisActavis Elizabeth LLCAnticonvulsantsDepomedGenericsGraliseHealth Medical PharmaLaw CrimeLegalNeurologicalPatentsPfizerUSA

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

Mylan wins motion to enjoin GSK from providing paroxetine CR to Apotex

17-07-2014

US generics drug major Mylan says that the US District Court for the District of New Jersey granted its…

ApotexGenericsGlaxoSmithKlineLegalMylanNeurologicalparoxetinePaxil-CRUSA

Glenmark Pharma to set up new manufacturing facility in USA

Glenmark Pharma to set up new manufacturing facility in USA

17-07-2014

Indian drugmaker Glenmark Pharmaceuticals plans to set up a new manufacturing facility at Monroe Corporate…

GenericsGlenmark PharmaceuticalsProductionUSA

Impax Labs receives subpoena over digoxin

Impax Labs receives subpoena over digoxin

16-07-2014

US generic drugmaker Impax Laboratories revealed in a Securities Exchange Commission filing that, on…

Cardio-vascularCardiologydigoxinGenericsImpax LaboratoriesLegalMarkets & MarketingUSA

FDA accepts Teva’s NDA for albuterol MDPI

FDA accepts Teva’s NDA for albuterol MDPI

15-07-2014

Israel-based generic giant Teva Pharmaceuticals Industries says that the US Food and Drug Administration…

albuterolExercise-induced bronchospasmGenericsPulmonologyRegulationRespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

US regulatory warnings on drug producers extend well beyond India

US regulatory warnings on drug producers extend well beyond India

14-07-2014

Hauled up by the US Food and Drug Administration for product recalls and quality issues, Indian pharmaceutical…

CiplaDr Reddy's LaboratoriesGenericsIndiaLupinProductionRanbaxy LaboratoriesRegulationSun PharmaceuticalUSA

Actavis confirms patent challenge to Duchesnay’s Diclegis

Actavis confirms patent challenge to Duchesnay’s Diclegis

12-07-2014

Ireland-based generics major Actavis on Friday confirmed that it has filed an Abbreviated New Drug Application…

ActavisDiclegisDuchesnayGenericsPatentsRegulationUSAWomen's Health

Acorda fights Actavis on generic of its multiple sclerosis drug Ampyra

Acorda fights Actavis on generic of its multiple sclerosis drug Ampyra

09-07-2014

Ireland-headquartered generics major Actavis has confirmed filing an Abbreviated New Drug Application…

Acorda TherapeuticsActavisAmpyradalfampridineGenericsLegalNeurologicalUSA

Mylan launches generic Micardis in USA

Mylan launches generic Micardis in USA

08-07-2014

US generic drugmaker Mylan has launched Telmisartan Tablets USP, 20mg, 40mg and 80mg, the generic version…

Boehringer IngelheimCardio-vascularGenericsMarkets & MarketingMicardisMylanRegulationTelmisartanUSA

Actavis and Forest to divest four generics to gain FTC OK for merger

01-07-2014

In order for Ireland-headquartered generics major Actavis to complete its previously-announced $25 billion…

ActavisForest LaboratoriesGeneric pharmaceuticalsGenericsHealth Medical PharmaMedicinePharmaceutical industryPharmacologyRegulationUSA

Indian generics sector hires India First Group to re-establish its reputation

Indian generics sector hires India First Group to re-establish its reputation

01-07-2014

USA-based generic drugmakers want high quality, low cost generic pharmaceuticals made in India and the…

GenericsHealthcareIndiaPricingUSA

FTC approves final order on Akorn’s acquisition of Hi-Tech

FTC approves final order on Akorn’s acquisition of Hi-Tech

22-06-2014

Following a public comment period, the US Federal Trade Commission on Friday approved a final order settling…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsUSAValeant Pharmaceuticals International

Teva reaches settlement with Perrigo in ProAir HFA patent case

Teva reaches settlement with Perrigo in ProAir HFA patent case

20-06-2014

Israeli generics giant Teva Pharmaceutical Industries has reached a settlement with Perrigo Pharmaceutical…

Catalent Pharma SolutionsGenericsLegalPatents & Trade marksPerrigoProair HFARespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

FTC amicus brief: Improper use of restricted drug distribution programs may impede generic competition

FTC amicus brief: Improper use of restricted drug distribution programs may impede generic competition

20-06-2014

The US Federal Trade Commission has filed an amicus brief in the New Jersey US District Court explaining…

CelgeneGenericsLegalMylanPharmaceuticalRegulationUSA

US health care providers have concerns on proposed FDA generic drug labeling rules

US health care providers have concerns on proposed FDA generic drug labeling rules

19-06-2014

A survey co-released today by the USA’s Generic Pharmaceutical Association (GPhA) and the National…

GenericsHealth Medical PharmaHealthcareMedicinePharmaceutical sciencesPharmacologyPhysicianRegulationUSA

Prime Therapeutics' 2013 overall net cost per Rx of $58.99 is industry-low for third consecutive year

Prime Therapeutics' 2013 overall net cost per Rx of $58.99 is industry-low for third consecutive year

17-06-2014

In 2013, US Pharmacy Benefit Manager (PBM) Prime Therapeutic's average net ingredient cost per prescription…

GenericsHealthcarePricingUSA

US Court denies appeal in Baraclude patent case

US Court denies appeal in Baraclude patent case

13-06-2014

US pharma major Bristol-Myers Squibb yesterday announced that the US Court of Appeals for the Federal…

Anti-viralsBaracludeBristol-Myers SquibbGenericsLegalPatentsTeva Pharmaceutical IndustriesUSA

Mylan launches generic Paraplatin Injection in USA

Mylan launches generic Paraplatin Injection in USA

09-06-2014

US generics major Mylan has launched carboplatin injection, 50mg/5ml, in multi-dose vials, which is the…

Bristol-Myers SquibbGenericsMarkets & MarketingMylanOncologyParaplatinRegulationUSA

1 to 25 of 84 results

Back to top